Go to content Go to the menu Go to the search

Quick access, personalized services


Advanced search


Claire de Thoisy-Méchin

Press Relations

Tel. +33 (0)1 44 27 23 34

Email: claire.de_thoisy-mechin@upmc.fr


In English:

Katherine Tyrka

International Press Relations

tel. +33 (0)1 44 27 51 05

Email: katherine.tyrka@upmc.fr

UPMC Signs an Agreement with the University of Pittsburgh

On July 12, 2017, Pierre and Marie Curie University (UPMC), Inserm and the CNRS signed a major agreement with the University of Pittsburgh (U.S.A.) to advance collaborative research and education in the fields of clinical medicine and biomedical sciences.

This agreement will enable researchers from these four prestigious institutions to cooperate on fundamental research, the development of innovative therapies and clinical trials, with an initial focus on ophthalmology, vision and neuroscience. The agreement also provides for the exchange of academic staff, the organization of joint conferences and the exchange of scientific, educational and scholarly materials.

The agreement, signed on July 12 at the French Embassy in Washington, D.C., highlights the important partnership between Pittsburgh and the French institutions that was initiated by the recent recruitment of Prof. José-Alain Sahel, M.D., expert on retinal diseases, chair of the Department of Ophthalmology at the Pittsburgh School of Medicine, and Director of the Eye Center at the University of Pittsburg (U.S.A.). Professor Sahel has kept his commitments in France as Director of the Institute of Vision (UPMC, Inserm, CNRS) and the See & Hear Foundation, and as a professor-researcher at UPMC.

“This agreement will further strengthen the robust scientific and educational partnerships between Pittsburgh and Paris, bringing to bear our outstanding intellectual capacities to address some of the most significant diseases that lead to blindness and vision impairment through basic and translational research,” said Prof. Sahel.

Arthur S. Levine, M.D., senior vice-chancellor for the health sciences and John and Gertrude Petersen Dean of Medicine stated,"Taking on an immense challenge like the quest to cure blindness requires that we not only have bold ideas, but also the brightest minds to work on them. The University of Pittsburgh is proud to be a part of this international partnership that will bring together the world-class scientific community at Pitt with researchers from France under the able leadership of Dr. Sahel."

The agreement was signed in the presence of Gérard Araud, Ambassador of France in the United States, by:

- Jean Chambaz, President of Pierre and Marie Curie University - Sorbonne University

- Sidney Wiener, Scientific Attaché, International Affairs, CNRS

- Yves Levy, CEO of Inserm

- Arthur Levine, Vice-Chancellor of the University of Pittsburgh and Dean of the Faculty of Medicine